Peripartum cardiomyopathy: a new successful setting for levosimendan.
Benezet-Mazuecos
Juan
J
de la Hera
Javier
J
D000328:Adult; D002316:Cardiotonic Agents / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006333:Heart Failure / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D006835:Hydrazones / Q000008:administration & dosage*; D007262:Infusions, Intravenous; D049590:Postpartum Period; D011247:Pregnancy; D011724:Pyridazines / Q000008:administration & dosage*; D018570:Risk Assessment; D012720:Severity of Illness Index; D000077464:Simendan; D016896:Treatment Outcome; D018487:Ventricular Dysfunction, Left / Q000175:diagnosis / Q000188:drug therapy*
D002316:Cardiotonic Agents; D006835:Hydrazones; D011724:Pyridazines; D000077464:Simendan